ADRA2C
Alpha-2C adrenergic receptor
Also known as: ADA2C_HUMAN, ADRA2L2, ADRA2RL2, ADRARL2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18825
- Gene
- ADRA2C
- Ensembl
- ENSG00000184160
- Chromosome
- 4
- Canonical length
- 462 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. These receptors have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. The mouse studies revealed that both the alpha2A and alpha2C subtypes were required for normal presynaptic control of transmitter release from sympathetic nerves in the heart and from central noradrenergic neurons. The alpha2A subtype inhibited transmitter release at high stimulation frequencies, whereas the alpha2C subtype modulated neurotransmission at lower levels of nerve activity. This gene encodes the alpha2C subtype, which contains no introns in either its coding or untranslated sequences. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
462 residues, UniProt reviewed canonical sequence.
>P18825|ADRA2C
1 MASPALAAAL AVAAAAGPNA SGAGERGSGG VANASGASWG PPRGQYSAGA VAGLAAVVGF
61 LIVFTVVGNV LVVIAVLTSR ALRAPQNLFL VSLASADILV ATLVMPFSLA NELMAYWYFG
121 QVWCGVYLAL DVLFCTSSIV HLCAISLDRY WSVTQAVEYN LKRTPRRVKA TIVAVWLISA
181 VISFPPLVSL YRQPDGAAYP QCGLNDETWY ILSSCIGSFF APCLIMGLVY ARIYRVAKLR
241 TRTLSEKRAP VGPDGASPTT ENGLGAAAGA GENGHCAPPP ADVEPDESSA AAERRRRRGA
301 LRRGGRRRAG AEGGAGGADG QGAGPGAAES GALTASRSPG PGGRLSRASS RSVEFFLSRR
361 RRARSSVCRR KVAQAREKRF TFVLAVVMGV FVLCWFPFFF SYSLYGICRE ACQVPGPLFK
421 FFFWIGYCNS SLNPVIYTVF NQDFRRSFKH ILFRRRRRGF RQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADRA2C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 102 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 102 nTPM
- cervix: 61 nTPM
- endometrium: 54 nTPM
- kidney: 33 nTPM
- basal ganglia: 24 nTPM
- prostate: 21 nTPM
Single-cell type
- endometrial stromal cells: 110 nCPM
- decidual stromal cells: 57 nCPM
- vascular smooth muscle cells: 46 nCPM
- smooth muscle cells: 41 nCPM
- retinal pigment epithelial cells: 30 nCPM
- fallopian secretory cells: 28 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 42 nTPM
- hypothalamus: 14 nTPM
- cerebral cortex: 13 nTPM
- amygdala: 11 nTPM
- pons: 11 nTPM
- thalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.5
- gnomAD missense Z
- 1.64
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting adrenergic receptor signaling pathway
- adrenergic receptor signaling pathway
- cell-cell signaling
- epidermal growth factor receptor signaling pathway
- G protein-coupled receptor signaling pathway
- negative regulation of epinephrine secretion
- negative regulation of insulin secretion
- negative regulation of norepinephrine secretion
- platelet activation
- positive regulation of MAPK cascade
- positive regulation of neuron differentiation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- regulation of smooth muscle contraction
- regulation of vasoconstriction
Molecular functions
- alpha-2A adrenergic receptor binding
- alpha2-adrenergic receptor activity
- epinephrine binding
- protein heterodimerization activity
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADRA2C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADRA2C as an antibody target. Whether an autoantibody or antibody against ADRA2C could matter depends on whether native ADRA2C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADRA2C is annotated at the cell surface, where native ADRA2C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADRA2C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...